These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 25665755

  • 21. Tamoxifen inhibits CDK5 kinase activity by interacting with p35/p25 and modulates the pattern of tau phosphorylation.
    Corbel C, Zhang B, Le Parc A, Baratte B, Colas P, Couturier C, Kosik KS, Landrieu I, Le Tilly V, Bach S.
    Chem Biol; 2015 Apr 23; 22(4):472-482. PubMed ID: 25865311
    [Abstract] [Full Text] [Related]

  • 22. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia.
    Nijboer CH, Heijnen CJ, Groenendaal F, van Bel F, Kavelaars A.
    Stroke; 2009 Oct 23; 40(10):3362-8. PubMed ID: 19628795
    [Abstract] [Full Text] [Related]

  • 23. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T, Zolton J, Shaffner R, Schnell B, Crescentini R, Wu Y, Zeng J, DelleDonne A, Obregon D, Tan J, Mullan M.
    J Neurosci Res; 2002 Aug 01; 69(3):362-72. PubMed ID: 12125077
    [Abstract] [Full Text] [Related]

  • 24. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
    Kumral A, Yesilirmak DC, Sonmez U, Baskin H, Tugyan K, Yilmaz O, Genc S, Gokmen N, Genc K, Duman N, Ozkan H.
    Brain Res; 2006 Oct 18; 1115(1):169-78. PubMed ID: 16938277
    [Abstract] [Full Text] [Related]

  • 25. Uridine protects against hypoxic-ischemic brain injury by reducing histone deacetylase activity in neonatal rats.
    Koyuncuoglu T, Turkyilmaz M, Goren B, Cetinkaya M, Cansev M, Alkan T.
    Restor Neurol Neurosci; 2015 Oct 18; 33(5):777-84. PubMed ID: 26410212
    [Abstract] [Full Text] [Related]

  • 26. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W, Allen ME, Rui Y, Ku L, Liu G, Bankston AN, Zheng JQ, Feng Y.
    J Neurosci; 2016 Nov 02; 36(44):11283-11294. PubMed ID: 27807169
    [Abstract] [Full Text] [Related]

  • 27. p25/CDK5 is partially involved in neuronal injury induced by radiofrequency electromagnetic field exposure.
    Zhang Y, She F, Li L, Chen C, Xu S, Luo X, Li M, He M, Yu Z.
    Int J Radiat Biol; 2013 Nov 02; 89(11):976-84. PubMed ID: 23786497
    [Abstract] [Full Text] [Related]

  • 28. Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats.
    Carloni S, Alonso-Alconada D, Girelli S, Duranti A, Tontini A, Piomelli D, Hilario E, Alvarez A, Balduini W.
    Pediatr Res; 2012 Oct 02; 72(4):400-6. PubMed ID: 22821058
    [Abstract] [Full Text] [Related]

  • 29. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats.
    Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH.
    Brain Res; 2007 May 11; 1145():227-38. PubMed ID: 17359943
    [Abstract] [Full Text] [Related]

  • 30. Low-dose GYKI-52466: prophylactic preconditioning confers long-term neuroprotection and functional recovery following hypoxic-ischaemic brain injury.
    Nayak PK, Kerr DS.
    Neuroscience; 2013 Mar 01; 232():128-38. PubMed ID: 23246617
    [Abstract] [Full Text] [Related]

  • 31. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
    Zheng YL, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W, Grant P, Pant HC.
    EMBO J; 2005 Jan 12; 24(1):209-20. PubMed ID: 15592431
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of the CDK5/caspase-3 Pathway by p5-TAT Protects Hippocampal Neurogenesis and Alleviates Radiation-induced Cognitive Dysfunction.
    Zhang J, Zhang Y, Xu M, Miao Z, Tian Y.
    Neuroscience; 2021 May 21; 463():204-215. PubMed ID: 33838288
    [Abstract] [Full Text] [Related]

  • 33. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P, Guan J, Mathai S, Zhang R, Wang X, Gustavsson M, Hagberg H, Mallard C.
    Dev Neurosci; 2007 May 21; 29(4-5):393-402. PubMed ID: 17762207
    [Abstract] [Full Text] [Related]

  • 34. Genetic deletion of neuronal pentraxin 1 expression prevents brain injury in a neonatal mouse model of cerebral hypoxia-ischemia.
    Thatipamula S, Al Rahim M, Zhang J, Hossain MA.
    Neurobiol Dis; 2015 Mar 21; 75():15-30. PubMed ID: 25554688
    [Abstract] [Full Text] [Related]

  • 35. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H, Chang L, Zhang H, Nie J, Zhang Z, Yang X, Vuong AM, Wang Z, Chen A, Niu Q.
    Toxicol Lett; 2017 Aug 05; 277():41-53. PubMed ID: 28559121
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J, Kritskiy O, Watson LA, Barker SJ, Dey D, Raja WK, Lin YT, Ko T, Cho S, Penney J, Silva MC, Sheridan SD, Lucente D, Gusella JF, Dickerson BC, Haggarty SJ, Tsai LH.
    J Neurosci; 2017 Oct 11; 37(41):9917-9924. PubMed ID: 28912154
    [Abstract] [Full Text] [Related]

  • 37. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
    Li G, Faibushevich A, Turunen BJ, Yoon SO, Georg G, Michaelis ML, Dobrowsky RT.
    J Neurochem; 2003 Jan 11; 84(2):347-62. PubMed ID: 12558997
    [Abstract] [Full Text] [Related]

  • 38. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL, Li BS, Amin ND, Albers W, Pant HC.
    Eur J Biochem; 2002 Sep 11; 269(18):4427-34. PubMed ID: 12230554
    [Abstract] [Full Text] [Related]

  • 39. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
    Sundaram JR, Poore CP, Sulaimee NH, Pareek T, Asad AB, Rajkumar R, Cheong WF, Wenk MR, Dawe GS, Chuang KH, Pant HC, Kesavapany S.
    J Neurosci; 2013 Jan 02; 33(1):334-43. PubMed ID: 23283346
    [Abstract] [Full Text] [Related]

  • 40. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H, Maddineni U, Ayala R, Morabito M, Volker J, Dikkes P, Ahlijanian MK, Tsai LH.
    J Neurosci; 2003 Apr 01; 23(7):2769-78. PubMed ID: 12684463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.